New Delhi, March 3 -- Maruti Suzuki recorded slight growth, whereas Hyundai and Tata Motors experienced a drop in sales in February, as market sluggishness persisted with subdued demand.

According to the US health regulator, Glenmark Pharma is withdrawing nearly 1.5 million bottles of a generic drug used to treat attention deficit hyperactivity disorder (ADHD) from the US market.

The company has been issued a show cause notice by the Directorate of Enforcement for alleged violations of specific provisions under the Foreign Exchange Management Act (FEMA) during the period from 2015 to 2019. The notice is related to the acquisition of two subsidiaries, Little Internet and Nearbuy India (previously Groupon), and involves certain directors ...